Xing Y - Search Results

1

DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.

Fan W, Xing Y, Yan S, Liu W, Ning J, Tian F, Wang X, Zhan Y, Luo L, Cao M, Huang J, Cai L. Fan W, et al. Among authors: xing y. Cancer Cell Int. 2024 Jun 13;24(1):208. doi: 10.1186/s12935-024-03382-6. Cancer Cell Int. 2024. PMID: 38872157 Free PMC article.

2

TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.

Xing Y, Meng Q, Chen X, Zhao Y, Liu W, Hu J, Xue F, Wang X, Cai L. Xing Y, et al. Oncotarget. 2016 May 24;7(21):30479-91. doi: 10.18632/oncotarget.8586. Oncotarget. 2016. PMID: 27058415 Free PMC article.

3

[Role of Hippo Signaling Pathway in Lung Cancer].

Liu Y, Xing Y, Cai L. Liu Y, et al. Among authors: xing y. Zhongguo Fei Ai Za Zhi. 2017 Sep 20;20(9):629-634. doi: 10.3779/j.issn.1009-3419.2017.09.07. Zhongguo Fei Ai Za Zhi. 2017. PMID: 28935017 Free PMC article. Review. Chinese.

4

TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W, Hu J, Li C, Cao M, Yan S, Huang J, Wang T, Cai L. Xing Y, et al. Cell Commun Signal. 2018 Jul 31;16(1):43. doi: 10.1186/s12964-018-0254-x. Cell Commun Signal. 2018. PMID: 30064446 Free PMC article.

5

LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.

Liu Y, Xing Y, Wang H, Yan S, Wang X, Cai L. Liu Y, et al. Among authors: xing y. Thorac Cancer. 2018 Dec;9(12):1725-1732. doi: 10.1111/1759-7714.12887. Epub 2018 Oct 1. Thorac Cancer. 2018. PMID: 30273983 Free PMC article.

6

Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.

Wang T, Xing Y, Meng Q, Lu H, Liu W, Yan S, Song Y, Xu X, Huang J, Cui Y, Jia D, Cai L. Wang T, et al. Among authors: xing y. J Exp Clin Cancer Res. 2019 Apr 25;38(1):174. doi: 10.1186/s13046-019-1162-7. J Exp Clin Cancer Res. 2019. PMID: 31023336 Free PMC article.

7

PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.

Wang H, Gu R, Tian F, Liu Y, Fan W, Xue G, Cai L, Xing Y. Wang H, et al. Among authors: xing y. Thorac Cancer. 2019 Nov;10(11):2124-2132. doi: 10.1111/1759-7714.13196. Epub 2019 Sep 30. Thorac Cancer. 2019. PMID: 31571378 Free PMC article.

8

Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.

Huang J, Lan X, Wang T, Lu H, Cao M, Yan S, Cui Y, Jia D, Cai L, Xing Y. Huang J, et al. Among authors: xing y. Oncogene. 2020 Feb;39(8):1739-1755. doi: 10.1038/s41388-019-1099-5. Epub 2019 Nov 18. Oncogene. 2020. PMID: 31740781

9

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy.

Song Y, Yan S, Fan W, Zhang M, Liu W, Lu H, Cao M, Hao C, Chen L, Tian F, Zhan Y, Cai L, Xing Y. Song Y, et al. Among authors: xing y. Front Cell Dev Biol. 2020 Jul 3;8:550. doi: 10.3389/fcell.2020.00550. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32719796 Free PMC article.

10

CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.

Cui Y, Song Y, Yan S, Cao M, Huang J, Jia D, Liu Y, Zhang S, Fan W, Cai L, Li C, Xing Y. Cui Y, et al. Among authors: xing y. Aging (Albany NY). 2020 Oct 25;12(20):20047-20068. doi: 10.18632/aging.103329. Epub 2020 Oct 25. Aging (Albany NY). 2020. PMID: 33099540 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,490 results

Search Page

Filters